Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis

被引:272
作者
Stadlbauer, Vanessa [1 ]
Mookerjee, Rajeshwar P. [1 ]
Hodges, Stephen [1 ]
Wright, Gavin A. K. [1 ]
Davies, Nathan A. [1 ]
Jalan, Rajiv [1 ]
机构
[1] UCL, Inst Hepatol, Liver Failure Grp, Div Med, London WC1E 6HX, England
基金
奥地利科学基金会;
关键词
alcoholic cirrhosis; neutrophil function; phagocytosis; probiotic; cytokine; toll-like receptor;
D O I
10.1016/j.jhep.2008.02.015
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: Endotoxaemia contributes to neutrophil dysfunction, infection risk and mortality in patients with alcoholic cirrhosis. As probiotics may decrease Gram-negative gut organisms, we hypothesised that probiotic treatment would restore neutrophil function. Methods: In an open-label study, patients with alcoholic cirrhosis (n = 12) received Lactobacillus casei Shirota (6.5 x 10(9)) 3 times daily for 4 weeks. Data were compared to healthy controls (n = 13) and cirrhotic patients (n = 8) who did not receive probiotics. Neutrophil oxidative burst, phagocytosis, toll-like-receptor (TLR) expression, plasma cytokines and ex vivo endotoxin-stimulated cytokine production were measured. Results: Baseline neutrophil phagocytic capacity in patients was significantly lower compared to healthy controls (73% versus 98%, p < 0.05), but normalised at the end of the study (n = 10, 100%, p < 0.05). No improvement was seen in disease controls. Soluble TNF-receptor (sTNFR)-1 and-2 and interleukin (IL)10 were significantly elevated in patients' plasma but did not change during the study. Ex vivo endotoxin-stimulated levels of sTNFR1, sTNFR2 and IL10 were significantly lower at the end of the study (p < 0.05). TLR2, 4 and 9 were overexpressed in patients. TLR4 expression normalised by the end of the study. Conclusions: Our data provide a proof-of-concept that probiotics restore neutrophil phagocytic capacity in cirrhosis, possibly by changing IL10 secretion and TLR4 expression, warranting larger randomised controlled and mechanistic studies. (c) 2008 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:945 / 951
页数:7
相关论文
共 41 条
  • [1] Probiotic use in clinical practice: what are the risks?
    Boyle, Robert J.
    Robins-Browne, Roy M.
    Tang, Mimi L. K.
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 2006, 83 (06) : 1256 - 1264
  • [2] CAMPBELL AC, 1981, CLIN EXP IMMUNOL, V45, P81
  • [3] Effect of administration of Lactobacillus casei Shirota on sodium balance in an infant with short bowel syndrome
    Candy, DCA
    Densham, L
    Lamont, LS
    Greig, M
    Lewis, J
    Bennett, H
    Griffiths, M
    [J]. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2001, 32 (04) : 506 - 508
  • [4] Neutrophil priming: pathophysiological consequences and underlying mechanisms
    Condliffe, AM
    Kitchen, E
    Chilvers, ER
    [J]. CLINICAL SCIENCE, 1998, 94 (05) : 461 - 471
  • [5] Meta-analysis: the effect of probiotic administration on antibiotic-associated diarrhoea
    Cremonini, F
    Di Caro, S
    Nista, EC
    Bartolozzi, F
    Capelli, G
    Gasbarrini, G
    Gasbarrini, A
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2002, 16 (08) : 1461 - 1467
  • [6] Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis
    D'Souza, AL
    Rajkumar, C
    Cooke, J
    Bulpitt, CJ
    [J]. BRITISH MEDICAL JOURNAL, 2002, 324 (7350): : 1361 - 1364
  • [7] Hepatic encephalopathy: A review of its pathophysiology and treatment
    Dbouk N.
    McGuire B.M.
    [J]. Current Treatment Options in Gastroenterology, 2006, 9 (6) : 464 - 474
  • [8] BLOOD POLYMORPHONUCLEAR DYSFUNCTION IN PATIENTS WITH ALCOHOLIC CIRRHOSIS
    FELIU, E
    GOUGEROT, MA
    HAKIM, J
    CRAMER, E
    AUCLAIR, C
    RUEFF, B
    BOIVIN, P
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1977, 7 (06) : 571 - 577
  • [9] Bacterial infections in cirrhosis:: Epidemiological changes with invasive procedures and norfloxacin prophylaxis
    Fernández, J
    Navasa, M
    Gómez, J
    Colmenero, J
    Vila, J
    Arroyo, V
    Rodés, J
    [J]. HEPATOLOGY, 2002, 35 (01) : 140 - 148
  • [10] FERRANTE A, 1994, J IMMUNOL, V152, P3998